As COVID-19 has led to a range of challenges for business, they have been forced to rethink and address their supply chain. Find KPMG insights on the related tax considerations and tax planning below.
July 30 | Walking the Tightrope of U.S.-China Tensions: Supply Chains Reconsidered
KPMG Advisory webcast | Discusses economic nationalism—characterized as a make-where-you-sell-and-buy-where-you-make approach—from an operations strategy perspective; the latest on the U.S.-China trade agreement and tax policies; and a framework to help identify a go-forward approach with considerations and characteristics such as supply alternatives, barriers to entry, capacity and quality with alternative, as well as overall trade, export control, customs, and tax influence.
June 25 | Supply Chain and the Rise of Economic Nationalism
KPMG Advisory webcast | Addresses economic nationalism from an operations strategy perspective; six competencies that will be critical to tearing down and rebuilding your supply chain operating model; how the supply chain model of the future will shift from equating value with lowest cost to a value framework encapsulating risk exposure, supply alternatives, tax considerations, and channel complexity; and additional types of supply chain risk factors that may emerge after COVID-19 recedes.
In case you missed ...
May 27 | COVID-19 Disruption in Consumer & Retail Webcast
KPMG webcast – Consumer & Retail | Discusses the toll disruption is taking on consumer and retail business supply chains and operations, focusing on tax and trade implications.
April 10 | Accelerating Duty Recovery and Reduction Strategies During an Economic Downturn
KPMG TradeWatch webcast | Covers lessons learned from recent duty recovery efforts and program implementations as well as steps organizations can take to potentially increase cost savings, a top priority for organizations during this economic downturn.
April 9 | COVID-19 Disruption in Life Sciences: Tax, Trade and Value Chain Implications
KPMG webcast - International Corridors | Discusses the impact of COVID-19 on the life sciences industry. Topics include implications of fluctuating production capacity and constrained resources; federal and international tax issues related to process and innovation R&D, changing asset value, inventory, increased capital needs and potential losses; and latest and potential future U.S. trade and customs developments affecting life sciences.
April 7 | Sanctions Screening: How Recent Enforcement Actions Will Impact Your Compliance Program
KPMG TradeWatch webcast | Discusses the challenges, pitfalls, and solutions for administering an automated restricted party screening system using smarter technology, as companies grapple with implementing compliance programs with fewer resources in light of COVID-19 developments.
July 31, 2020
In this Bloomberg Tax article, the authors discuss the role of substance in transfer pricing in light of OECD's Action 8-10 and DEMPE, BEPS 2.0, and COVID-19.
July 6, 2020
Economies around the world are in the midst of a severe downturn brought about by measures taken to contain Covid-19. As a result, multinational enterprises' transfer prices may need to be adjusted. In this Bloomberg Tax article, the authors discuss some potential approaches for adjusting profit benchmarks for controlled entities in the CPM/TNMM context, consistent with the arm's-length standard.
July 1, 2020
In this Journal of International of Tax article, the authors focus on some of the significant international tax and transfer pricing issues, including supply chain, consumer demand, and cash flow, arising from companies' activities disrupted by TCJA and COVID-19.
June 29, 2020
In this Tax Notes Federal article, the authors examine key trends affecting the life sciences industry in the COVID-19 pandemic and the associated transfer pricing considerations.
May 25, 2020
This article, which appeared in Tax Notes Federal, explains how recent changes to the U.S. advance pricing agreement (APA) confirm the potential to amend existing APAs and highlight the value of the APA process to address extraordinary economic disruption through tailored long-term solutions.
May 18, 2020
COVID-19 is causing multinational corporations to reassess transfer pricing (TP) policies and consider making TP adjustments or additional payments. Customs risks and opportunities exist, and in the current high-tariff environment, the duty costs can be significant. This KPMG article highlights related compliance and planning issues, which may require advance customs, accounting, and TP coordination and planning.
May 11, 2020
This Bloomberg Tax article discusses significant challenges posed by COVID-19 disruption and some of the key issues for life sciences companies from tax, trade and valuation perspectives, covering supply chain, financing and cash flow, and research and development. Possible post-COVID-19 trends, opportunities, and issues for the industry are also discussed.
March 26, 2020
Many multinational companies deploy limited risk structures, such as contract manufacturing or limited risk distribution, in their global operations, including China.This Bloomberg Tax article sets out what taxpayers should consider in analyzing the steps to be taken to manage transfer pricing risk in light of declines in profits of limited risk companies resulting from the demand supply shocks caused by the COVID-19 outbreak.